How Long Can a Dog Live With Heartworms: Treated vs. Not

A dog that receives standard heartworm treatment has an excellent chance of living a normal lifespan, while an untreated dog faces progressive heart and lung damage that typically proves fatal within two to three years of the worms reaching maturity. The gap between those two outcomes is enormous, but the details matter more than a simple “treated vs. not” framing suggests. Disease stage at the time of diagnosis, the number of adult worms present, and whether complications arise during treatment all shape how long a particular dog can expect to live.

What Happens When Heartworm Goes Untreated

Adult heartworms lodge in the pulmonary arteries and, in heavy infections, extend into the right side of the heart. They physically obstruct blood flow and trigger chronic inflammation of the artery walls. Over months and years, the arteries thicken and stiffen, the right side of the heart works harder to push blood through damaged vessels, and the lungs gradually lose their ability to exchange oxygen efficiently. This cascade is what veterinarians refer to when they stage heartworm disease from mild (Class 1) to severe (Class 3-4).

In the early months, a dog with a light worm burden may look perfectly healthy. Some dogs remain in this deceptively quiet phase for a year or more, which is partly why owners sometimes underestimate the urgency of treatment. But the worms keep growing, mating, and producing microfilariae (larval offspring) that circulate in the bloodstream, and the arterial damage accumulates whether the dog is coughing or not.

Without treatment, most dogs with a moderate to heavy infection develop exercise intolerance, a persistent cough, and weight loss within one to two years. As the disease advances, kidney markers and liver enzymes climb. A study categorizing dogs into mild versus advanced groups found that dogs in the advanced group had significantly higher blood urea nitrogen, creatinine, and markers of red blood cell distortion, along with lower electrolyte levels, reflecting widespread organ stress beyond just the lungs.

The timeline to death varies. Dogs with lighter infections and robust hearts may survive three or even four years, though with declining quality of life. Dogs with heavy burdens or pre-existing cardiac issues deteriorate faster. There is no reliable “expiration date” because worm count, breed size, activity level, and individual cardiovascular reserve all interact. What is reliable is the direction: untreated heartworm disease is progressive and ultimately fatal.

Survival Rates With Standard Treatment

The standard treatment protocol involves a series of injections of melarsomine, a drug that kills adult heartworms. Most protocols also include a preparatory phase with doxycycline to target a bacterium called Wolbachia that lives inside the worms. Killing off Wolbachia before the worms die reduces the inflammatory surge that occurs when dead worms break apart in the bloodstream.¹

The survival numbers from clinical studies are reassuring, especially for dogs diagnosed early. A study of 283 dogs treated with melarsomine in Germany reported that two dogs died during the treatment period, a rate under 1%, and neither death was conclusively caused by the drug itself. At six-month follow-up, none of the 221 dogs retested were still antigen-positive, meaning the treatment had cleared the infection entirely.²

A separate study of 157 dogs with asymptomatic or mild heartworm disease found that all dogs survived to discharge, and every follow-up antigen test performed more than three months after the final melarsomine injection came back negative.³ For dogs caught in the early stages, treatment amounts to a temporary ordeal followed by a return to a normal, healthy life.

The picture gets more complicated for dogs diagnosed later. A study at Louisiana State University tracked 50 dogs through treatment and found that about half experienced minor complications like injection site soreness, vomiting, or lethargy. More than half developed respiratory signs such as coughing or labored breathing attributed to progressive disease and worm death. Seven dogs, or 14%, died during the treatment period. Critically, none of the dogs classified as Class 1 at diagnosis experienced major adverse effects or death.⁴

The contrast across these studies tells you something important: the mortality risk of treatment scales with how sick the dog already is. A dog diagnosed on a routine screening with no symptoms has a very different risk profile than a dog brought in with a swollen belly and a hacking cough.

Why Disease Stage Changes Everything

Heartworm disease is typically classified into four stages. Class 1 dogs test positive but show few or no symptoms. Class 2 dogs have a mild cough or reduced exercise tolerance. Class 3 dogs show significant signs including persistent cough, fatigue, difficulty breathing, and changes visible on X-rays. Class 4 is caval syndrome, a life-threatening emergency where worms physically clog the heart’s valves and incoming blood vessels.

Dogs in the advanced group (Class 3-4) show measurably different blood work from mild-stage dogs. One study found that advanced-stage dogs had significantly higher markers of kidney stress, liver damage, and coagulation abnormality, along with lower concentrations of key electrolytes like sodium and calcium. The severity of these lab values correlated directly with the heartworm class, meaning the sicker the dog appeared clinically, the more deranged the bloodwork.⁵

This matters because those organ-level changes do not always fully reverse even after successful treatment. A dog whose kidneys and liver have been under strain for months may recover from the heartworms but carry residual organ damage. The pulmonary arteries, once scarred by chronic inflammation, do not return to their original state. Dogs treated at Class 1 or 2 tend to bounce back completely. Dogs treated at Class 3 may survive and improve substantially but could have a shortened lifespan compared to a dog that was never infected.

Complications During Treatment

Dead worms do not simply vanish. When melarsomine kills adult heartworms, the decomposing worm fragments travel deeper into the smaller branches of the pulmonary arteries, where they form clots. Pulmonary thromboembolism, which is essentially clot-related blockage in the lung’s blood vessels, is an expected and unavoidable consequence of successful treatment.⁶ In most dogs, the body reabsorbs these fragments over weeks, but during that window, the dog is at real risk if it overexerts itself.

This is why veterinarians insist on strict exercise restriction during and after treatment, often for two months or more following the final injection. A dog that runs, jumps, or gets too excited pushes more blood through already compromised lung vessels, which can turn a manageable embolism into a fatal one. It is one of the hardest parts of treatment for owners: keeping an otherwise energetic dog calm and confined for weeks on end.

The complications reported across studies tend to fall into predictable categories:

Injection site reactions: Soreness, swelling, or firm lumps at the intramuscular injection site, reported in roughly 2-9% of dogs depending on the injection number.
Gastrointestinal upset: Vomiting, diarrhea, and loss of appetite, usually mild and temporary.
Respiratory signs: Coughing and labored breathing caused by dead worm fragments in the lungs. This is the most common serious complication and the one most closely tied to worm burden.
Lethargy and behavioral changes: Many owners report that their dogs seem depressed or unusually tired during treatment, likely from a combination of pain at the injection site and the systemic effects of worm die-off.

For mild-stage dogs, these complications are generally manageable and temporary. The German study of 283 dogs found that coughing after the first injection occurred in about 13% of dogs and dropped to about 5% after the third injection, with gastrointestinal signs affecting under 4%.² The LSU study’s higher complication and mortality rates reflect a population that included more advanced-stage dogs.⁴

The Slow-Kill Approach and Why It Is Controversial

Some owners encounter a protocol called “slow kill,” which involves giving a monthly heartworm preventive (a macrocyclic lactone) without the melarsomine injections. The idea is that the preventive kills incoming larvae and eventually shortens the lifespan of adult worms, allowing the infection to burn out over a year or two. It sounds gentler and is significantly cheaper, which makes it appealing on the surface.

The problem is that during the entire slow-kill period, adult worms remain alive in the pulmonary arteries, continuing to cause damage. Research has found that the slow-kill method may be acceptable only for dogs with low worm burdens in the mildest disease classes. For dogs with heavier infections and noticeable symptoms, slow kill alone does not adequately reduce the pathological changes, and additional medications like steroids and anti-clotting drugs are needed to minimize complications.⁷

There is also a diagnostic problem with slow kill. Dogs on long-term macrocyclic lactones can develop immune complexes that bind to heartworm antigens, hiding them from standard blood tests. One study found that over half of dogs managed with the slow-kill protocol who tested antigen-negative on standard assays actually converted to positive when their blood samples were heat-treated to break apart those immune complexes.⁸ In other words, an owner on the slow-kill path may be told their dog is heartworm-free when it is not, allowing ongoing arterial damage that nobody knows about.

The American Heartworm Society does not endorse slow kill as a primary treatment. When melarsomine is available and the dog is stable enough to receive it, the standard adulticide protocol remains the recommended approach. Slow kill exists as a fallback for dogs who genuinely cannot tolerate melarsomine, not as a first choice.

Caval Syndrome and Emergency Situations

Caval syndrome represents the extreme end of untreated heartworm disease. It occurs when the worm burden is so heavy that worms physically obstruct the tricuspid valve and the vena cava, the large vein returning blood to the heart. Blood flow backs up catastrophically, red blood cells are mechanically sheared as they pass through the tangle of worms, and the dog develops acute collapse, dark urine from hemolysis, and labored breathing. Without intervention, caval syndrome is almost always rapidly fatal.

The standard emergency treatment is physical extraction of the worms using a long catheter-based retrieval tool, typically threaded through the jugular vein. A study examining cardiopulmonary function in dogs with caval syndrome found that among 15 dogs with spontaneous caval syndrome who underwent worm extraction, all recovered. However, 10 other dogs with spontaneous caval syndrome either died or were euthanized. The dogs that did not survive had significantly higher right-side heart pressures before the procedure, suggesting their hearts were already too compromised.⁹

There is also some limited evidence that in rare cases, medical stabilization alone can resolve caval syndrome without surgical extraction. A case series documented five dogs with caval syndrome that were treated with medications to reduce pulmonary artery pressure and support heart function in preparation for scheduled worm extraction. In all five, the worms spontaneously migrated back into the pulmonary arteries within hours to days, resolving the immediate emergency.¹⁰ The authors were careful to note that this was an unexpected finding in a small number of dogs and should not replace the standard recommendation for extraction.

Dogs That Live Longer Than Expected Without Full Treatment

Occasionally, a dog with heartworms lives far longer than the typical prognosis would predict. A study tracking dogs with intracardiac heartworms, a particularly severe presentation, found that among five dogs managed medically without extraction, one died within 26 days but four were still alive at follow-up periods ranging from roughly five months to over two and a half years.¹¹ These are not dogs that were doing fine; they had worms inside the heart itself. But with medical management, some lived considerably longer than you might expect.

These outlier cases are worth knowing about because they illustrate that heartworm prognosis is not a fixed countdown. Supportive care, reduced activity, and medications to manage pulmonary hypertension and right-sided heart failure can extend survival meaningfully even when full adulticide treatment is not an option. They do not, however, change the fundamental recommendation: if your dog can tolerate standard treatment, that remains the path most likely to lead to a normal lifespan.

The Role of Lung Damage and Pulmonary Hypertension

One of the less visible consequences of heartworm disease is the effect on the lungs themselves, separate from the worms and the arteries. The chronic arterial damage and poor blood flow through the lungs leads to secondary lung disease, which in turn causes low blood oxygen levels. That oxygen deprivation triggers the pulmonary arteries to constrict further, creating a feedback loop of worsening pressure and worsening oxygenation.

Research on heartworm-infected dogs has shown that much of the elevated pulmonary artery pressure in these dogs is actually driven by this hypoxia-induced vasoconstriction rather than by permanent structural damage alone. When infected dogs were given supplemental oxygen, their pulmonary pressures dropped substantially, while hypoxic conditions made the pressures worse.¹² This is clinically useful because it means oxygen therapy can provide real, measurable relief for dogs in respiratory distress from heartworm disease, both during treatment and in palliative situations.

It also means that some of the cardiopulmonary compromise seen in heartworm disease is reversible if the underlying infection is cleared and the lungs are given time to heal. Dogs whose pulmonary hypertension is primarily driven by active vasoconstriction rather than fixed arterial scarring stand to recover more of their cardiovascular function after treatment.

Climate, Geography, and Reinfection Risk

Heartworm is transmitted by mosquitoes, and the risk of infection is tied directly to climate. The parasite requires a minimum accumulation of warmth, measured in heat development units, for the larval stage to mature inside the mosquito to the point where it can infect a dog. In cooler climates, the transmission season is compressed into the warmest months. A study tracking heartworm transmission windows across several cities in Ontario found that the earliest exposure risk in some years began as early as late May in warmer areas, while in cooler northern locations the window did not open until mid-July or even early August.¹³

The same study modeled what would happen with a 1°C rise in average temperature and found that the transmission window shifted earlier by a median of about 4-7 days, depending on the location. That might sound small, but it adds up over years and extends into regions that previously saw little heartworm activity. For dog owners, the practical takeaway is that heartworm prevention calendars based on older climate patterns may no longer be accurate, and year-round prevention is increasingly recommended even in temperate areas.

Reinfection is a real concern for dogs that have completed treatment. Clearing an existing infection does not confer immunity. A dog that finishes melarsomine therapy in September and misses its preventive the following June can be reinfected and back where it started. Consistent monthly prevention after treatment is not optional — it is the only thing standing between your dog and a second round of arterial damage.

Doxycycline’s Role Before Treatment

The pre-treatment doxycycline phase, typically lasting about a month before melarsomine injections begin, targets the Wolbachia bacteria that live symbiotically inside heartworms. When worms die, these bacteria spill into the bloodstream and amplify the inflammatory response, contributing to the lung and vascular damage that makes the post-treatment recovery period risky.¹

Doxycycline treatment before the kill phase has been shown to reduce markers of systemic inflammation. However, researchers have been cautious about overstating the benefit. One study noted that while the blood markers of inflammation did decrease after doxycycline, these are indirect indicators and do not specifically measure whether the lungs are actually better protected during the worm die-off phase. The relationship between the short-term improvement in inflammation markers and what happens later when worms are actually dying remains uncertain.¹⁴ Still, the rationale is sound enough that doxycycline is a standard part of the treatment protocol, and skipping it would mean letting a known source of inflammation go unaddressed.

What You Can Reasonably Expect

If your dog has just been diagnosed with heartworm disease, the stage at diagnosis is the single strongest predictor of how this story ends. A dog caught at Class 1 or 2 who completes standard treatment has a very high probability of clearing the infection entirely and living out its expected lifespan with no lasting effects. The studies bear this out: survival in mild cases approached 100% across multiple treatment cohorts, and follow-up antigen tests consistently came back clean.³

For dogs diagnosed at more advanced stages, the math is still strongly in favor of treatment over doing nothing. Even in the LSU cohort, which included sicker dogs and reported a 14% mortality rate during treatment, the alternative of no treatment meant certain progressive decline. The dogs that died during treatment were concentrated among the most advanced cases, not the overall population of heartworm-positive dogs.

An untreated dog with a moderate infection is looking at roughly two to three years of declining health before heart failure or pulmonary complications end its life. A treated dog at the same stage faces a difficult few months of restricted activity and potential complications, followed by a good chance at years of healthy life. The risk-benefit calculus is not close. Treatment is harder, more expensive, and more stressful than prevention. But for a dog already infected, it is the difference between a terminal trajectory and a recoverable one.

1
PubMed. Evaluation of different dosages of doxycycline during the adulticide treatment of heartworm (Dirofilaria immitis) in dogs
2
PubMed Central. Adulticide treatment with melarsomine: outcome in 283 heartworm-positive dogs in Germany
3
PubMed Central. Further variation of the adulticide protocol for the treatment of canine heartworm infection: can it be even shorter and cost less?
4
PubMed. Outcome of a heartworm treatment protocol in dogs presenting to Louisiana State University from 2008 to 2011: 50 cases
5
BioMed Central / PubMed Central. Clinicopathologic variables according to disease severity in dogs with heartworm disease
6
PubMed. Variation of D-dimer values as assessment of pulmonary thromboembolism during adulticide treatment of heartworm disease in dogs
7
PubMed. Evaluation of cardiopulmonary and inflammatory markers in dogs with heartworm infection treated using the slow kill method
8
BioMed Central. False negative antigen tests in dogs infected with heartworm and placed on macrocyclic lactone preventives
9
American Journal of Veterinary Research. Cardiopulmonary function values before and after heartworm removal in dogs with caval syndrome
10
PubMed. Resolution of caval syndrome during initial hemodynamic stabilization in dogs with heartworm disease
11
Parasites & Vectors. Management and outcome of intracardiac heartworms in dogs
12
PubMed Central. Postadulticide pulmonary hypertension of canine heartworm disease: successful treatment with oxygen and failure of antihistamines
13
Europe PMC. Estimation of the onset of exposure risk for Dirofilaria immitis (heartworm) in selected cities in Ontario from 1996 to 2023
14
PubMed Central. Comparison of two doxycycline dosages on inflammatory and stress response in dogs naturally infected with Dirofilaria immitis